Our Commitment

Our ambition is to drive innovation, create value in areas of unmet medical need and find solutions for humans and animals living in underserved communities – to enable a healthier, sustainable and more equitable future.

Today, we are already helping millions of people worldwide live longer, healthier lives. But our ultimate goal is to create social impact for the entire population – capable of serving every patient. To achieve this, we address health equity and wellbeing across the whole patient continuum of care: from pharmaceutical innovation over prevention and healthcare delivery to tackling equitable access.

We focus on rapid innovation, integrating sustainability along our entire value chain and fostering multi-stakeholder collaboration. In particular to improve the lives of people and animals living in underserved communities.

Our framework: Sustainable Development for Generations

Our sustainability framework entitled “Sustainable Development for Generations” is based on three pillars. It incorporates initiatives we have been implementing for many years, continuously evolving them in consideration of shifting sustainability challenges, and in alignment with the UN Sustainable Development Goals. We strive to embed them into our core business, which is uniquely positioned to address the intertwined connection between humans, animals, and the environment.

Our sustainability programs

In 2023 we evolved our strategy further, to focus on nine sustainability programs that sharpen our focus on health equity and where we believe our company makes a relevant contribution to society. These programs are Innovation, Disease Prevention, Access, Healthcare Delivery Support, Social Engagement Models, Impact through our People, Responsible & Sustainable Sourcing, Sustainable Medicines and Decarbonization & Water Management.

Our commitments

By 2030, we aim to achieve the following commitments:

• MORE HEALTH : Expanding access to healthcare for 50 million people in underserved communities, investing 35 billion EUR in health innovation and research to tackle non-communicable diseases and an additional 250 million EUR in partnerships to combat emerging infectious diseases.
• MORE POTENTIAL : Our aim is to positively impact 50 million people in underserved communities by empowering and supporting our employees, partners, and innovative social entrepreneurs.
• MORE GREEN : We will become carbon-neutral in our company operations by 2030 (Scope 1 and 2). We will also significantly reduce the resource footprint across the value chain in the same period, despite our growing business activities.

Defining Underserved Communities

At Boehringer Ingelheim, a streamlined definition of who underserved communities are helps us better understand which barriers they face, their concrete needs and how our initiatives can deliver the most impactful and sustainable solutions.

Five ways to include more diversity in clinical trials

By embracing diversity in clinical trials, Boehringer Ingelheim enables more equitable and inclusive healthcare.

Our commitment to respect Human Rights

A central element of our corporate responsibility.

Joint Modern Slavery & Child Labor Statement 2023

This statement describes our measures against forced labor and child labor.